135 related articles for article (PubMed ID: 804420)
1. Investigations in enzyme replacement therapy in lipid storage diseases.
Brady RO; Pentchev PG; Gal AG
Fed Proc; 1975 Apr; 34(5):1310-5. PubMed ID: 804420
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy in Gaucher's and Fabry's disease.
Pentchev PG
Ann Clin Lab Sci; 1977; 7(3):251-3. PubMed ID: 404951
[TBL] [Abstract][Full Text] [Related]
3. Genetic errors and enzyme replacement strategies.
Brady RO
Res Publ Assoc Res Nerv Ment Dis; 1983; 60():181-93. PubMed ID: 6130585
[No Abstract] [Full Text] [Related]
4. Haematological aspects of lipid storage diseases.
Brady RO
Acta Haematol Pol; 1977; 8(2):103-12. PubMed ID: 407769
[No Abstract] [Full Text] [Related]
5. The lipid storage diseases: new concepts and control.
Brady RO
Ann Intern Med; 1975 Feb; 82(2):257-61. PubMed ID: 163609
[TBL] [Abstract][Full Text] [Related]
6. Heritable catabolic and anabolic disorders of lipid metabolism.
Brady RO
Metabolism; 1977 Mar; 26(3):329-45. PubMed ID: 13262
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal storage diseases.
Brady RO
Pharmacol Ther; 1982; 19(3):327-36. PubMed ID: 6821325
[No Abstract] [Full Text] [Related]
8. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
Fabrega S; Lehn P
J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
[TBL] [Abstract][Full Text] [Related]
9. The lipidoses: morphologic changes in the nervous system in Gaucher's disease, GM2 gangliosidoses and Niemann-Pick disease.
Arey JB
Ann Clin Lab Sci; 1975; 5(6):475-88. PubMed ID: 812418
[TBL] [Abstract][Full Text] [Related]
10. An appraisal of human trials in enzyme replacement therapy of genetic diseases.
Tager JM; Hamers MN; Schram AW; Van den Bergh FA; Rietra PJ; Loonen C; Koster JF; Slee R
Birth Defects Orig Artic Ser; 1980; 16(1):343-59. PubMed ID: 6778527
[No Abstract] [Full Text] [Related]
11. Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice.
Sly WS
Mo Med; 2004; 101(2):100-4. PubMed ID: 15119106
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic applications of sphingolipid hydrolyzing enzymes.
Brady RO
Curr Top Cell Regul; 1985; 26():39-50. PubMed ID: 3935381
[No Abstract] [Full Text] [Related]
13. Enzyme replacement therapy for the sphingolipidoses.
Brady RO; Pentchev PG; Gal AE; Hibbert SR; Quirk JM; Mook GE; Kusiak JW; Tallman JF; Dekaban AS
Adv Exp Med Biol; 1976; 68():523-32. PubMed ID: 820173
[No Abstract] [Full Text] [Related]
14. [Gaucher disease type 1--therapeutic results of enzyme substitution].
Steensberg J; Nielsen KG; Brandt NJ
Ugeskr Laeger; 1998 Jun; 160(26):3929-30. PubMed ID: 9656836
[TBL] [Abstract][Full Text] [Related]
15. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
Brady RO; Tallman JF; Johnson WG; Gal AE; Leahy WR; Quirk JM; Dekaban AS
N Engl J Med; 1973 Jul; 289(1):9-14. PubMed ID: 4196713
[No Abstract] [Full Text] [Related]
16. Sphingolipidoses.
Yatsu FM
Calif Med; 1971 Apr; 114(4):1-6. PubMed ID: 5551302
[TBL] [Abstract][Full Text] [Related]
17. The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.
Brady RO; James SP; Barranger JA
Prog Liver Dis; 1982; 7():331-46. PubMed ID: 6810410
[No Abstract] [Full Text] [Related]
18. Newer aspects of some interesting lipid storage diseases: Tay-Sachs and Gaucher's diseases.
Beutler E
West J Med; 1977 Jan; 126(1):46-54. PubMed ID: 831367
[No Abstract] [Full Text] [Related]
19. Biochemical approaches to the nosology of nervous system defects, II.
Brady RO
Birth Defects Orig Artic Ser; 1971 Feb; 7(1):33-6. PubMed ID: 4376033
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and therapy of Gaucher disease].
Ehlen C; Heintges T; Niederau C
Med Klin (Munich); 1995 May; 90(5):284-90. PubMed ID: 7791695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
